Subtle affinity-enhancing mutations in a myelin oligodendrocyte glycoprotein-specific TCR alter specificity and generate new self-reactivity.
Subtle affinity-enhancing mutations in a myelin oligodendrocyte glycoprotein-specific TCR alter specificity and generate new self-reactivity.
复制标题
DOI:
10.4049/jimmunol.0804377
复制
发表时间:
2009-04-01
期刊:
影响因子:
--
通讯作者:
Geiger TL
中科院分区:
文献类型:
--
作者:
Udyavar A;Alli R;Nguyen P;Baker L;Geiger TL
We describe a simple iterative approach to augment TCR affinity, which we studied using a myelin oligodendroglial glycoprotein (MOG)-specific TCR. We hypothesized that single amino acid modifications in T-cell receptor (TCR) CDR3 could enhance TCR sensitivity through focal interactions with antigenic peptide while minimizing the risk of cross-reactivity observed previously in TCRs more broadly mutagenized using in vitro evolution techniques. We show that this iterative method can indeed generate TCR with antigen sensitivity 100-fold greater than the parental receptor, and can endow TCR with co-receptor independence. However, we also find that single amino acid mutations in the CDR3 can alter TCR fine specificity, affecting recognition requirements for antigen residues over most of the length of the MHC binding groove. Further, minimal changes in surface-exposed CDR3 amino acids, even the addition of a single hydroxyl group or conversion of a methyl or sulfhydryl moiety to a hydroxyl, can confer modified antigen-specific TCR with new self reactivity. In vivo modeling of modified TCR through retroviral TCR gene transfer into Rag−/− mice confirmed the biological significance of these altered reactivities, though also demonstrated the feasibility of producing antigen-specific, positively selecting, co-receptor independent receptors with markedly increased antigen sensitivity. These results affirm the possibility of readily generating affinity-enhanced TCR for therapeutic purposes, but demonstrate that minimal changes in TCR CDR3 structure can promote self reactivity and thereby emphasize the importance of caution in validating receptors with even subtle alterations prior to clinical application.
登录
查看更多内容
影响因子:
56.9
作者:
Morgan, Richard A.;Dudley, Mark E.;Rosenberg, Steven A.
通讯作者:
Rosenberg, Steven A.
影响因子:
56.9
作者:
HUNT, DF;MICHEL, H;SETTE, A
通讯作者:
SETTE, A
影响因子:
100.3
作者:
Bluestone, Jeffrey A.;Thomson, Angus W.;Weiner, Howard L.
通讯作者:
Weiner, Howard L.
影响因子:
15.9
作者:
Delarasse, C;Daubas, P;Pham-Dinh, D
通讯作者:
Pham-Dinh, D
影响因子:
46.9
作者:
Li, Y;Moysey, R;Boulter, JM
通讯作者:
Boulter, JM